Flash
›
AnaptysBio, Inc. (ANAB) Deep Dive Video
AnaptysBio, Inc. (ANAB) Deep Dive Video
Summary
AnaptysBio is a newly streamlined royalty vehicle whose upside depends on Jemperli’s oncology growth, Sagard cash-flow reversion, and a decisive legal outcome against GSK/Tesaro.
View ANAB stock page
·
Read the ANAB research report
Loading the video player…